Jump to content

LUMINA

What if a blood sample could help predict how lung cancer will develop and respond to treatment? LUMINA aims to turn this possibility into reality through AI-powered digital twins for more precise and personalised cancer care.

In LUMINA, we develop personalised digital twins that combine clinical data, medical imaging, pathology and blood-based biomarkers.

By modelling disease progression and treatment response, these AI-powered representations will help clinicians anticipate risks, compare treatment options and make more informed decisions.

KEY INNOVATIONS

Personalised Digital Twins

We develop personalised digital twins that integrate multiple data sources, including clinical information, medical imaging, pathology data, and blood-based biomarkers.

AI-Powered Clinical Decision Support

The digital twins model disease progression and treatment response, helping clinicians assess risks, compare treatment options, and make more informed decisions for individual patients.

Blood-to-Image Innovation

Our core innovation is the BRONCHI Digital Twin, which combines generative AI with physics-informed modelling and investigates how routine blood biomarkers can enhance the accuracy and richness of patient models.

We transform lung cancer care through AI-powered digital twins

LUMINA aims to advance predictive, personalised lung cancer care and create technologies that could eventually be adapted to other cancers.

Read more about objectives and impact

Partners